StockData
Wave Life Sciences, Inc. logo

Wave Life Sciences, Inc. (WVE) stock

WVENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 10/3046% below fair value
$2.84−0.03 (-1.05%)

Close on Nov 17, 2026Market cap $560.13MP/E –Yield –

Wave Life Sciences r&d expenses

Research and development expenses are spending on new products and technology.

Wave Life Sciences's R&D Expenses for the twelve months ending Sep 30, 2026 was $205.39M, up 17.6% year over year. For fiscal 2025 it was $182.78M, up 14.5% from the year before. Over ten years it grew 35.0% a year on average. The highest annual figure on record is $182.78M in fiscal 2025.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$182.78M+14.5%
FY2024Dec 31, 2024$159.68M+22.8%
FY2023Dec 31, 2023$130.01M+12.2%
FY2022Dec 31, 2022$115.86M-4.9%
FY2021Dec 31, 2021$121.88M-6.9%
FY2020Dec 31, 2020$130.94M-25.4%
FY2019Dec 31, 2019$175.43M+30.5%
FY2018Dec 31, 2018$134.43M+69.5%
FY2017Dec 31, 2017$79.31M+94.3%
FY2016Dec 31, 2016$40.82M+350.7%
FY2015Dec 31, 2015$9.06M+278.2%
FY2014Dec 31, 2014$2.40M+24.7%
FY2013Dec 31, 2013$1.92M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$53.84M+17.4%
Q2 FY2026Jun 30, 2026$51.29M+18.0%
Q1 FY2026Mar 31, 2026$47.44M+16.8%
Q4 FY2025Dec 31, 2025$52.81M+18.3%
Q3 FY2025Sep 30, 2025$45.87M+11.4%
Q2 FY2025Jun 30, 2025$43.47M+7.6%
Q1 FY2025Mar 31, 2025$40.62M+21.5%
Q4 FY2024Dec 31, 2024$44.65M+31.0%
Q3 FY2024Sep 30, 2024$41.20M+30.2%
Q2 FY2024Jun 30, 2024$40.39M+21.2%
Q1 FY2024Mar 31, 2024$33.45M+8.0%
Q4 FY2023Dec 31, 2023$34.07M+9.6%
Q3 FY2023Sep 30, 2023$31.64M+14.7%
Q2 FY2023Jun 30, 2023$33.31M+12.0%
Q1 FY2023Mar 31, 2023$30.98M+12.8%
Q4 FY2022Dec 31, 2022$31.08M+20.6%
Q3 FY2022Sep 30, 2022$27.58M-11.3%
Q2 FY2022Jun 30, 2022$29.73M-6.0%
Q1 FY2022Mar 31, 2022$27.47M-17.7%
Q4 FY2021Dec 31, 2021$25.76M-14.2%
Q3 FY2021Sep 30, 2021$31.09M+9.9%
Q2 FY2021Jun 30, 2021$31.64M+0.5%
Q1 FY2021Mar 31, 2021$33.39M-18.9%
Q4 FY2020Dec 31, 2020$30.03M-38.9%
Q3 FY2020Sep 30, 2020$28.28M-36.6%
Q2 FY2020Jun 30, 2020$31.48M-24.3%
Q1 FY2020Mar 31, 2020$41.16M+2.6%
Q4 FY2019Dec 31, 2019$49.13M+23.4%
Q3 FY2019Sep 30, 2019$44.59M+35.6%
Q2 FY2019Jun 30, 2019$41.61M+27.8%
Q1 FY2019Mar 31, 2019$40.11M+37.4%
Q4 FY2018Dec 31, 2018$39.81M+56.9%
Q3 FY2018Sep 30, 2018$32.88M+63.6%
Q2 FY2018Jun 30, 2018$32.55M+70.4%
Q1 FY2018Mar 31, 2018$29.20M+98.1%
Q4 FY2017Dec 31, 2017$25.37M+81.3%
Q3 FY2017Sep 30, 2017$20.10M–
Q2 FY2017Jun 30, 2017$19.10M–
Q1 FY2017Mar 31, 2017$14.74M–
Q4 FY2016Dec 31, 2016$14.00M–

More Wave Life Sciences figures

See a number that looks wrong?